查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1615472

全球生長因子市場：按類型、來源、傳遞方法、分銷管道、應用、治療領域 - 預測 2025-2030

Growth Factors Market by Type, Source, Delivery Method, Distribution Channel, Application, Therapeutic Area - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生長因子市場規模為18.5億美元，預計2024年將達到19.8億美元，複合年成長率為7.17%，2030年將達到30.1億美元。

市場研究中的成長因素通常是指推動特定市場擴張的因素。這包括技術進步、不斷變化的消費行為、監管變化、經濟狀況等。作為360iResearch的市場研究分析師，了解這些因素非常重要，因為它定義了市場潛力並有助於策略規劃。這些成長因素對於評估市場需求、設定可實現的業務目標和識別新興趨勢是必要的。它還可以應用於行銷策略制定、產品開拓、市場競爭分析等。最終用途範圍包括技術、醫療保健、零售和金融等行業，這些行業在很大程度上依賴此類見解來保持領先地位。

主要市場統計
基準年[2023] 18.5億美元
預測年份 [2024] 19.8億美元
預測年份 [2030] 30.1億美元
複合年成長率（%） 7.17%

在市場洞察方面，技術進步成為主要的成長影響因素，為人工智慧主導的分析和個人化客戶服務等領域提供了機會。不斷變化的法規環境既帶來了挑戰，也帶來了機會。如果公司能夠快速適應，他們就可以利用變革來獲得競爭優勢。影響消費者購買力的經濟趨勢也很重要，需要積極調整策略。在數位轉型和永續性方面發現了最新的潛在商機，鼓勵企業利用綠色解決方案和數位平台進行創新。將鼓勵對提高效率和減少環境影響的技術進行投資。

然而，資料隱私問題、某些領域的市場飽和以及世界事件的不可預測性等限制可能會抑製成長。公司必須透過投資強大的網路安全、多樣化投資組合併確保營運靈活性來應對這些挑戰。競爭加劇和消費者偏好快速變化等競爭因素需要持續監控和調整策略。潛在的創新領域包括開發更聰明的演算法來進行即時資料分析，以及創造更身臨其境的虛擬客戶體驗。由於市場的本質仍然是動態和競爭的，公司必須優先考慮創新和敏捷性，以捕捉成長並在不斷變化的環境中保持彈性。

市場動態：揭示快速發展的生長因子市場的關鍵市場洞察

供給和需求的動態交互作用正在改變生長因子市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 對再生醫學的需求不斷增加，以因應慢性病的增加
    • 消費者對個人化和量身定做的醫療保健策略的偏好不斷增加
    • 擴大組織工程、幹細胞和再生治療的研究活動
  • 市場限制因素
    • 規模化和製造成長因素的複雜性
  • 市場機會
    • 改進生技藥品製造流程並更有效地生產生技藥品
    • 擴大生長因子在化妝品應用上的使用
  • 市場挑戰
    • 對生長因子安全性和有效性的擔憂

波特五力：駕馭生長因子市場的策略工具

波特的五力架構是了解生長因子市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解生長因子市場的外部影響

外部宏觀環境因素對於塑造生長因子市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 成長因素 了解市場競爭狀況

成長因素市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣成長因素市場供應商的績效評估

FPNV 定位矩陣是評估成長因子市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和推薦的成長因素描繪了市場成功之路

生長因子市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們越來越需要再生醫學來應對慢性疾病的增加。
      • 消費者對個人化和客製化醫療保健策略的偏好日益成長
      • 擴大組織工程、幹細胞和再生醫學領域的研究活動
    • 抑制因素
      • 生長因子縮放和製造複雜性
    • 機會
      • 改進生物製造製程並更有效地生產生技藥品
      • 擴大生長因子在化妝品領域的應用
    • 任務
      • 對生長因子安全性和有效性的擔憂
  • 市場區隔分析
    • 類型：表皮生長因子的使用由於其在眼科和創傷治療中的作用而不斷增加
    • 應用：生長因子在治療增加慢性病的巨大潛力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生長因子市場：依類型

  • 表皮生長因子
  • 纖維母細胞生長因子
  • 肝細胞生長因子
  • 類胰島素生長因子
  • 神經生長因子
  • 血小板衍生生長因子
  • 轉化生長因子
  • 血管內皮生長因子

第7章生長因子市場：依來源分類

  • 動物源性生長因子
  • 人源性生長因子

第8章按交付方式分類的生長因子市場

  • 注射給藥
  • 口服給藥
  • 局部給藥

第9章生長因子市場：按通路

  • 離線
  • 線上

第10章生長因子市場：依應用分類

  • 化妝品
    • 頭髮護理
    • 護膚
  • 藥品
    • 癌症治療
    • 組織再生
    • 傷口癒合
  • 調查
    • 細胞培養基
    • 藥物發現

第11章依治療領域分類的生長因子市場

  • 心血管疾病
  • 皮膚科
  • 神經系統疾病
  • 腫瘤學
  • 眼科
  • 整形外科

第12章美洲生長因子市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太生長因子市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲的生長因子市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biocon Biologics Limited 的生物相似藥阿柏西普獲得 FDA核准
    • ABenz Therapeutics 獲得 1.5 億美元資金，用於加強腫瘤產品線並推進藥物開發
    • 丹納赫公司已完成對 Abcam Limited 的收購，以加強其生命科學產品組合。
  • 戰略分析和建議

公司名單

  • Abcam PLC by Danaher Corporation
  • Akron Biotech
  • Applied Biological Materials Inc.
  • Bio-Techne Corporation
  • Biopharm GmbH
  • Cell Guidance Systems LLC
  • Cell Signaling Technology, Inc.
  • Creative Bioarray
  • F. Hoffmann-La Roche AG
  • Gemini BioProducts LLC
  • Johnson & Johnson Services, Inc.
  • Leadgene Biomedical, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience Inc.
  • Miltenyi Biotec BV & Co. KG
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Repligen Corporation
  • Reprocell Inc.
  • Rockland Immunochemicals, Inc.
  • Sartorius AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8E22B619330C

The Growth Factors Market was valued at USD 1.85 billion in 2023, expected to reach USD 1.98 billion in 2024, and is projected to grow at a CAGR of 7.17%, to USD 3.01 billion by 2030.

Growth factors in market research typically refer to the elements driving the expansion of a particular market. These can include technological advancements, evolving consumer behaviors, regulatory changes, and economic conditions. In the role of a Market Research Analyst at 360iResearch, understanding these factors is crucial as they define the market's potential and help in strategic planning. These growth factors are necessary for assessing market demands, setting feasible business goals, and identifying emerging trends. They have applications in formulating marketing strategies, product development, and competitive analysis. The end-use scope includes industries like technology, healthcare, retail, and finance, which heavily rely on such insights to stay ahead.

KEY MARKET STATISTICS
Base Year [2023] USD 1.85 billion
Estimated Year [2024] USD 1.98 billion
Forecast Year [2030] USD 3.01 billion
CAGR (%) 7.17%

In terms of market insights, technological advancements stand out as a significant growth influencer, offering opportunities in areas such as AI-driven analytics and personalized customer interactions. The ever-evolving regulatory environment presents both challenges and opportunities; companies can leverage changes for competitive advantage if they can quickly adapt. Economic trends that influence consumer purchasing power are also critical, necessitating proactive adjustments in strategies. The latest potential opportunities are seen in digital transformation and sustainability, with businesses encouraged to innovate in eco-friendly solutions and digital platforms. A recommendation would be to invest in technology that enhances efficiency and reduces environmental impact.

However, limitations such as data privacy concerns, market saturation in certain sectors, and the unpredictability of global events can deter growth. Companies must navigate these by investing in robust cybersecurity, diversifying portfolios, and ensuring agile operations. Challenging factors like fierce competition and rapidly changing consumer preferences demand continuous monitoring and adaptation of strategies. Potential areas for innovation include developing smarter algorithms for real-time data analysis and creating more immersive virtual customer experiences. The nature of the market remains dynamic and competitive, necessitating businesses to prioritize innovation and agility to capture growth and maintain resilience in a constantly shifting landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Growth Factors Market

The Growth Factors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising need for regenerative medicines to manage the increasing prevalence of chronic diseases
    • Growing consumer preference for personalized and tailored healthcare strategies
    • Expanding research activities in tissue engineering, stem cell, and regenerative therapies
  • Market Restraints
    • Complexities in scaling and manufacturing of growth factors
  • Market Opportunities
    • Improvements in biomanufacturing processes and more efficient production of biologics
    • Expanding usage of growth factors in cosmetic applications
  • Market Challenges
    • Safety and efficacy concerns of growth factor

Porter's Five Forces: A Strategic Tool for Navigating the Growth Factors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Growth Factors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Growth Factors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Growth Factors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Growth Factors Market

A detailed market share analysis in the Growth Factors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Growth Factors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Growth Factors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Growth Factors Market

A strategic analysis of the Growth Factors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Growth Factors Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Akron Biotech, Applied Biological Materials Inc., Bio-Techne Corporation, Biopharm GmbH, Cell Guidance Systems LLC, Cell Signaling Technology, Inc., Creative Bioarray, F. Hoffmann-La Roche AG, Gemini BioProducts LLC, Johnson & Johnson Services, Inc., Leadgene Biomedical, Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., Miltenyi Biotec B.V. & Co. KG, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Repligen Corporation, Reprocell Inc., Rockland Immunochemicals, Inc., Sartorius AG, Sino Biological, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Growth Factors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Epidermal Growth Factor, Fibroblast Growth Factor, Hepatocyte Growth Factor, Insulin-like Growth Factor, Nerve Growth Factor, Platelet-Derived Growth Factor, Transforming Growth Factor, and Vascular Endothelial Growth Factor.
  • Based on Source, market is studied across Animal-derived Growth Factors and Human-derived Growth Factors.
  • Based on Delivery Method, market is studied across Injectable Administration, Oral Administration, and Topical Administration.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Application, market is studied across Cosmetic, Medical, and Research. The Cosmetic is further studied across Hair Care and Skin Care. The Medical is further studied across Cancer Treatment, Tissue Regeneration, and Wound Healing. The Research is further studied across Cell Culture Media and Drug Discovery.
  • Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Dermatology, Neurological Disorders, Oncology, Ophthalmology, and Orthopedics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for regenerative medicines to manage the increasing prevalence of chronic diseases
      • 5.1.1.2. Growing consumer preference for personalized and tailored healthcare strategies
      • 5.1.1.3. Expanding research activities in tissue engineering, stem cell, and regenerative therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in scaling and manufacturing of growth factors
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in biomanufacturing processes and more efficient production of biologics
      • 5.1.3.2. Expanding usage of growth factors in cosmetic applications
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and efficacy concerns of growth factor
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of epidermal growth factor due to its roles in ophthalmology and wound healing
    • 5.2.2. Application: High potential of growth factors in medical for treating growing number of chronic diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Growth Factors Market, by Type

  • 6.1. Introduction
  • 6.2. Epidermal Growth Factor
  • 6.3. Fibroblast Growth Factor
  • 6.4. Hepatocyte Growth Factor
  • 6.5. Insulin-like Growth Factor
  • 6.6. Nerve Growth Factor
  • 6.7. Platelet-Derived Growth Factor
  • 6.8. Transforming Growth Factor
  • 6.9. Vascular Endothelial Growth Factor

7. Growth Factors Market, by Source

  • 7.1. Introduction
  • 7.2. Animal-derived Growth Factors
  • 7.3. Human-derived Growth Factors

8. Growth Factors Market, by Delivery Method

  • 8.1. Introduction
  • 8.2. Injectable Administration
  • 8.3. Oral Administration
  • 8.4. Topical Administration

9. Growth Factors Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Growth Factors Market, by Application

  • 10.1. Introduction
  • 10.2. Cosmetic
    • 10.2.1. Hair Care
    • 10.2.2. Skin Care
  • 10.3. Medical
    • 10.3.1. Cancer Treatment
    • 10.3.2. Tissue Regeneration
    • 10.3.3. Wound Healing
  • 10.4. Research
    • 10.4.1. Cell Culture Media
    • 10.4.2. Drug Discovery

11. Growth Factors Market, by Therapeutic Area

  • 11.1. Introduction
  • 11.2. Cardiovascular Diseases
  • 11.3. Dermatology
  • 11.4. Neurological Disorders
  • 11.5. Oncology
  • 11.6. Ophthalmology
  • 11.7. Orthopedics

12. Americas Growth Factors Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Growth Factors Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Growth Factors Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Biocon Biologics Limited secured FDA approval for biosimilar aflibercept
    • 15.3.2. Avenzo Therapeutics secured USD 150 million to boost oncology pipeline and advance drug development
    • 15.3.3. Danaher Corporation completed the acquisition of Abcam Limited to enhance life sciences portfolio
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC by Danaher Corporation
  • 2. Akron Biotech
  • 3. Applied Biological Materials Inc.
  • 4. Bio-Techne Corporation
  • 5. Biopharm GmbH
  • 6. Cell Guidance Systems LLC
  • 7. Cell Signaling Technology, Inc.
  • 8. Creative Bioarray
  • 9. F. Hoffmann-La Roche AG
  • 10. Gemini BioProducts LLC
  • 11. Johnson & Johnson Services, Inc.
  • 12. Leadgene Biomedical, Inc.
  • 13. Lonza Group Ltd.
  • 14. Merck KGaA
  • 15. Meridian Bioscience Inc.
  • 16. Miltenyi Biotec B.V. & Co. KG
  • 17. Prospec-Tany Technogene Ltd.
  • 18. Proteintech Group, Inc.
  • 19. Repligen Corporation
  • 20. Reprocell Inc.
  • 21. Rockland Immunochemicals, Inc.
  • 22. Sartorius AG
  • 23. Sino Biological, Inc.
  • 24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GROWTH FACTORS MARKET RESEARCH PROCESS
  • FIGURE 2. GROWTH FACTORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GROWTH FACTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GROWTH FACTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GROWTH FACTORS MARKET SIZE, BY EPIDERMAL GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GROWTH FACTORS MARKET SIZE, BY FIBROBLAST GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GROWTH FACTORS MARKET SIZE, BY HEPATOCYTE GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GROWTH FACTORS MARKET SIZE, BY INSULIN-LIKE GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GROWTH FACTORS MARKET SIZE, BY NERVE GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GROWTH FACTORS MARKET SIZE, BY PLATELET-DERIVED GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GROWTH FACTORS MARKET SIZE, BY TRANSFORMING GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GROWTH FACTORS MARKET SIZE, BY VASCULAR ENDOTHELIAL GROWTH FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GROWTH FACTORS MARKET SIZE, BY ANIMAL-DERIVED GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GROWTH FACTORS MARKET SIZE, BY HUMAN-DERIVED GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GROWTH FACTORS MARKET SIZE, BY INJECTABLE ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GROWTH FACTORS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GROWTH FACTORS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GROWTH FACTORS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GROWTH FACTORS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GROWTH FACTORS MARKET SIZE, BY COSMETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GROWTH FACTORS MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GROWTH FACTORS MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GROWTH FACTORS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GROWTH FACTORS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GROWTH FACTORS MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GROWTH FACTORS MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GROWTH FACTORS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GROWTH FACTORS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GROWTH FACTORS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GROWTH FACTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GROWTH FACTORS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GROWTH FACTORS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 202. TAIWAN GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 211. THAILAND GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 220. VIETNAM GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 239. DENMARK GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 248. EGYPT GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 257. FINLAND GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 266. FRANCE GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 275. GERMANY GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 284. ISRAEL GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 293. ITALY GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 302. NETHERLANDS GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 311. NIGERIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 320. NORWAY GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 327. POLAND GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 329. POLAND GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 336. QATAR GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 338. QATAR GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 345. RUSSIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 347. RUSSIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 354. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 356. SAUDI ARABIA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 362. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY COSMETIC, 2018-2030 (USD MILLION)
  • TABLE 363. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 364. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 365. SOUTH AFRICA GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 366. SPAIN GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 367. SPAIN GROWTH FACTORS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 368. SPAIN GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 369. SPAIN GROWTH FACTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 370. SPAIN GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 371. SPAIN GROWTH FACTORS MARKET SIZE, BY